EUVIMEDEUVIMED entdecken
Crossref

Evaluation of anti-staphylococcal activity and acute toxicity of hexane extracts of Macaranga occidentalis (Mull. Arg.) Mull. Arg (Euphobiaceae)

Prosper E. K. Lele, Soreille R. Y. Sofeu, Aimé G. Fankam, Jason B. T. Kuete, Remi R. Nsatar, Victor Kuete

Investigational Medicinal Chemistry and Pharmacology · 31.01.2026 · 9 (1) · 1-8

DOI: 10.31183/imcp.2026.00133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigational Medicinal Chemistry and Pharmacology, online erschienen am 28.02.2026. Verfasst von Prosper E. K. Lele und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Macaranga occidentalis is well known in traditional medicine for the treatment of various ailments like bruises, boils, cuts, sores, and diarrhea. This study aimed to investigate in vitro and in vivo the anti-staphylococcal activity of Macaranga occidentalis extracts on selected Staphylococcus aureus, including multidrug resistance (MDR) isolates. Moreover, the acute toxicity of the active extract was assessed.

Methods

Extracts were prepared by maceration of M. occidentalis in hexane. The in vitro activity of the extracts was determined using the broth microdilution method. The in vivo anti-staphylococcal activity and acute toxicity of the hexane extract were assessed in Wistar rats.

Results

The hexane leaves and bark extracts of M. occidentalis demonstrated antibacterial activity, with minimum inhibitory concentrations (MIC) ranging from 64 to 2048 μg/mL. In vivo, the hexane leaf extract (the most active) significantly reduced the bacterial load in S. aureus D021-infected Wistar rats after the tenth day of the experiment. It showed no toxic effect on blood cells and even enhanced hemoglobin production. Furthermore, at a dose of 5000 mg/kg body weight, this extract showed no signs of toxicity in rats, indicating that the median lethal dose (LD50) is greater than 5000 mg/kg body weight.

Conclusion

Macaranga occidentalis extracts, especially its leaf hexane extract, constitute promising alternative therapeutic sources for infections caused by MDR Staphylococcus aureus. Therefore, further studies including its subacute and chronic toxicity, as well as the identification of its active ingredients, should be envisaged.

Zitieren

APA

Lele, P. E. K., Sofeu, S. R. Y., Fankam, A. G., Kuete, J. B. T., Nsatar, R. R., & Kuete, V. (2026). Evaluation of anti-staphylococcal activity and acute toxicity of hexane extracts of Macaranga occidentalis (Mull. Arg.) Mull. Arg (Euphobiaceae). Investigational Medicinal Chemistry and Pharmacology, 9(1), 1-8. https://doi.org/10.31183/imcp.2026.00133

Vancouver

Lele PEK, Sofeu SRY, Fankam AG, Kuete JBT, Nsatar RR, Kuete V. Evaluation of anti-staphylococcal activity and acute toxicity of hexane extracts of Macaranga occidentalis (Mull. Arg.) Mull. Arg (Euphobiaceae). Investigational Medicinal Chemistry and Pharmacology. 2026;9(1):1-8. doi:10.31183/imcp.2026.00133

BibTeX
@article{Lele2026,
  author = {Lele, Prosper E. K. and Sofeu, Soreille R. Y. and Fankam, Aimé G. and Kuete, Jason B. T. and Nsatar, Remi R. and Kuete, Victor},
  title = {Evaluation of anti-staphylococcal activity and acute toxicity of hexane extracts of Macaranga occidentalis (Mull. Arg.) Mull. Arg (Euphobiaceae)},
  journal = {Investigational Medicinal Chemistry and Pharmacology},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {1--8},
  doi = {10.31183/imcp.2026.00133}
}
Kostenlos starten →